[HTML][HTML] Epidemiology of respiratory infections during the COVID-19 pandemic

N Principi, G Autore, G Ramundo, S Esposito - Viruses, 2023 - mdpi.com
To face the COVID-19 outbreak, a wide range of non-pharmaceutical interventions (NPIs)
aimed at limiting the spread of the virus in communities, such as mask-wearing, hand …

[HTML][HTML] Estimating the transmission dynamics of SARS-CoV-2 Omicron BF. 7 in Beijing after adjustment of the zero-COVID policy in November–December 2022

K Leung, EHY Lau, CKH Wong, GM Leung, JT Wu - Nature medicine, 2023 - nature.com
We tracked the effective reproduction number (R t) of the predominant severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variant Omicron BF. 7 in Beijing in …

The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review

A Sarkar, S Omar, A Alshareef, K Fanous… - Human Vaccines & …, 2023 - Taylor & Francis
The Omicron variant of SARS-CoV-2 was detected in October 2021 and exhibited high
transmissibility, immune evasion, and reduced severity when compared to the earlier …

[HTML][HTML] Swift and extensive Omicron outbreak in China after sudden exit from 'zero-COVID'policy

EE Goldberg, Q Lin, EO Romero-Severson… - Nature …, 2023 - nature.com
In late 2022, China transitioned from a strict 'zero-COVID'policy to rapidly abandoning nearly
all interventions and data reporting. This raised great concern about the presumably-rapid …

[HTML][HTML] Key considerations during the transition from the acute phase of the COVID-19 pandemic: a narrative review

P Rzymski, M Pokorska-Śpiewak, T Jackowska… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

Electrochemical and optical-based systems for SARS-COV-2 and various pathogens assessment

S Ahmed, A Ansari, MA Siddiqui, M Imran… - Advances in Natural …, 2023 - iopscience.iop.org
A critical step in the process for preventing and identifying emergencies relating to health,
safety, and welfare is the testing and quick diagnosis of microbial pathogens. Due to the fast …

[HTML][HTML] SARS-CoV-2 related antibody-dependent enhancement phenomena in vitro and in vivo

EE Nakayama, T Shioda - Microorganisms, 2023 - mdpi.com
Antibody-dependent enhancement (ADE) is a phenomenon in which antibodies produced in
the body after infection or vaccination may enhance subsequent viral infections in vitro and …

Comparative effectiveness of bivalent BA. 4-5 and BA. 1 mRNA booster vaccines among adults aged≥ 50 years in Nordic countries: nationwide cohort study

NW Andersson, EM Thiesson, U Baum, N Pihlström… - bmj, 2023 - bmj.com
Objective To estimate the effectiveness of the bivalent mRNA booster vaccines containing
the original SARS-CoV-2 and omicron BA. 4-5 or BA. 1 subvariants as the fourth dose …

Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind …

GH Dayan, N Rouphael, SR Walsh, A Chen… - The Lancet …, 2023 - thelancet.com
Background COVID-19 vaccines with alternative strain compositions are needed to provide
broad protection against newly emergent SARS-CoV-2 variants of concern. This study …

[HTML][HTML] In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB. 1.9. 1, XBB. 1.9. 3, XBB. 1.5, XBB. 1.16, XBB. 2.4, BQ …

AA Pochtovyi, DD Kustova, AE Siniavin, IV Dolzhikova… - Vaccines, 2023 - mdpi.com
The spread of COVID-19 continues, expressed by periodic wave-like increases in morbidity
and mortality. The reason for the periodic increases in morbidity is the emergence and …